Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.3200
+0.0070 (2.24%)
At close: Sep 18, 2026, 4:00 PM EDT
0.3280
+0.0080 (2.50%)
After-hours: Sep 18, 2026, 7:34 PM EDT

SNTI Revenue

Senti Biosciences Holdings had revenue of $17.00K in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $55.00K. In the year 2025, Senti Biosciences Holdings had annual revenue of $22.00K.

Revenue (ttm)
$55.00K
Revenue Growth
n/a
P/S Ratio
181.21
Revenue / Employee
$1,410
Employees
39
Market Cap
9.97M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202522.00K--
Dec 31, 2024---
Dec 31, 20232.56M-1.73M-40.25%
Dec 31, 20224.29M1.53M55.23%
Dec 31, 20212.76M2.20M387.81%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Immuron5.34M
Vistagen Therapeutics2.50M
CytoMed Therapeutics669.28K
Exicure500.00K
Aprea Therapeutics5.19K
Revenue Rankings